tiprankstipranks
Royalty Pharma Reports Strong Q3 2024 Results
PremiumCompany AnnouncementsRoyalty Pharma Reports Strong Q3 2024 Results
14d ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
15d ago
Royalty Pharma reports Q3 revenue $565M, consensus $696.1M
Premium
The Fly
Royalty Pharma reports Q3 revenue $565M, consensus $696.1M
15d ago
Royalty Pharma Strikes Deal on FDA-Approved Schizophrenia Drug
PremiumCompany AnnouncementsRoyalty Pharma Strikes Deal on FDA-Approved Schizophrenia Drug
2M ago
PureTech Health announces FDA approval of KarXT
Premium
The Fly
PureTech Health announces FDA approval of KarXT
2M ago
Royalty Pharma price target raised to $51 from $50 at Goldman Sachs
Premium
The Fly
Royalty Pharma price target raised to $51 from $50 at Goldman Sachs
3M ago
Royalty Pharma price target raised to $51 from $48 at Morgan Stanley
PremiumThe FlyRoyalty Pharma price target raised to $51 from $48 at Morgan Stanley
4M ago
Agios Pharmaceuticals price target raised to $53 from $44 at RBC Capital
Premium
The Fly
Agios Pharmaceuticals price target raised to $53 from $44 at RBC Capital
6M ago
Royalty Pharma downgraded to Neutral from Buy at UBS
Premium
The Fly
Royalty Pharma downgraded to Neutral from Buy at UBS
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100